The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Mitochondrial DNA damage and atherosclerosis
Open accessAbstract
Mitochondria are often regarded as the cellular powerhouses through their ability to generate ATP, the universal fuel for metabolic processes. However, in recent years mitochondria have been recognised as critical regulators of cell death, inflammation, metabolism, and the generation of reactive oxygen species (ROS). Thus, mitochondrial dysfunction directly promotes cell death, inflammation, and oxidative stress and alters metabolism. These are key processes in atherosclerosis and there is now evidence that mitochondrial DNA (mtDNA) damage leads to mitochondrial dysfunction and promotes atherosclerosis directly. In this review we discuss the recent evidence for and mechanisms linking mtDNA defects and atherosclerosis and suggest areas of mitochondrial biology that are potential therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interaction of TLR9 with mtDNA activates the nuclear factor kappa B (NF-jB) signaling and increases the expression of other pro-inflammatory cytokines such as tumor necrosis factor-a (TNF-a), interleukin (IL)-6, IL-1b (Julian et al, 2013;Yu & Bennett, 2014;Zhang et al, 2014).”
From Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency (2018) · cites this paper as Yu & Bennett, 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084 · cited 1×
“7 Mitochondrial DNA damage and atherosclerosis Mitochondria are the powerhouses of the cell, responsible for generating ATP through oxidative phosphorylation, with ROS formed as a by-product [8].”
BackgroundAMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602 · cited 1×
“AMPK activation has multiple effects, including inhibition of gluconeogenesis and adipogenesis [59] that could lead to reduced adiposity.”
BackgroundNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · cited 2×
“Importantly NLRP3 inflammasome activation and increased IL1β release may promote atherosclerosis [52].”
BackgroundCirculating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · cited 2×
“These inflammatory mtDNA motifs stimulate TLR9, leading to nuclear factor kappa beta (NFκβ) activation and transcription of inflammatory cytokines [45](Figure 3).”
BackgroundMitochondria: In Sickness and in Health
Nunnari, J., & Suomalainen, A. (2012) · Cell · doi:10.1016/j.cell.2012.02.035 · Cited by 3,479 · cited 1×
“We increasingly recognise that mtDNA defects not only impact upon mitochondrial and cellular function but whole organism metabolism [58] .”
BackgroundNakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,651 · cited 1×
“Lipids, too, are a target of ROS and lipid oxidation is well-recognised as an important event in atherogenesis [22].”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Lood, C., Blanco, L. P., Purmalek, M. M., Carmona-Rivera, C., De Ravin, S. S., Smith, C. K., Malech, H. L., Ledbetter, J. A., Elkon, K. B., & Kaplan, M. J. (2016) · Nature Medicine · doi:10.1038/nm.4027 · Cited by 1,570
“Indeed, mitochondria are one of the major sites of ROS generation and enhanced mitochondrial ROS has been associated with chronic inflammatory conditions 37 .”
Metabolism of vascular smooth muscle cells in vascular diseases
Shi, J., Yang, Y., Cheng, A., Xu, G., & He, F. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00220.2020 · Cited by 366
Thinking outside the nucleus: Mitochondrial DNA copy number in health and disease
Castellani, C. A., Longchamps, R. J., Sun, J., Güallar, E., & Arking, D. E. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.06.004 · Cited by 350
“In CVD, mtDNA-CN was associated with the activation of proatherogenic genes, atherogenesis, plaque instability, thrombosis via LDL oxidation, and altered electrophysiology (Aggarwal and Makielski, 2013; Berliner and Heinecke, 1996; Erusalimsky, 2009; Jain et al., 2013; Liu et al., 2010; Lo et al., 2005; Sánchez-Santos…”
BackgroundInflammation and mitochondrial dysfunction: A vicious circle in neurodegenerative disorders?
van Horssen, J., van Schaik, P. E. M., & Witte, M. E. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.06.050 · Cited by 298
Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency
Rodríguez‐Nuevo, A., Díaz‐Ramos, A., Noguera, E., Díaz‐Sáez, F., Duran, X., Muñoz, J. P., Romero, M., Plana, N., Sebastián, D., Tezze, C., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201796553 · Cited by 207
“Interaction of TLR9 with mtDNA activates the nuclear factor kappa B (NF-j B) signaling and increases the expression of other pro-inflammatory cytokines such as tumor necrosis factor-a (TNF-a ), interleukin (IL)-6, IL-1 b (Julian et al , 2013; Yu & Bennett, 2014; Zhang et al , 2014).”
Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs
Kang, E., Wang, X., Tippner-Hedges, R., Ma, H., Folmes, C. D. L., Gutiérrez, N. M., Lee, Y., Dyken, C. V., Ahmed, R., Li, Y., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.02.005 · Cited by 216
“…suggests that mtDNA mutations increase in frequency in a variety of aged human tissues, leading to a pathogenic loss of respiratory capacity (Yu and Bennett, 2014), the extent and role of detectable high-level heteroplasmic or homoplasmicmtDNAmutations remains uncertain (Schon et al., 2012).”
BackgroundMitochondrial DNA in the regulation of innate immune responses
Fang, C., Wei, X., & Wei, Y. (2015) · Protein & Cell · doi:10.1007/s13238-015-0222-9 · Cited by 174
“Mitochondrial DNA, similar to that of its bacterial ancestor’s, consists of a circular loop and contains significant number of unmethylated DNA as CpG islands (Yu and Bennett, 2014).”
InfluentialChen, B., Li, H., Ou, G., Ren, L., Yang, X., & Zeng, M. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1974-z · Cited by 159
Pham, P. T., Fukuda, D., Nishimoto, S., Kim‐Kaneyama, J., Lei, X., Takahashi, Y., Sato, T., Tanaka, K., Suto, K., Kawabata, Y., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab249 · Cited by 152
Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation
Yang, L., Youngblood, H. A., Wu, C., & Zhang, Q. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00197-z · Cited by 147
Mitochondrial metabolism and the control of vascular smooth muscle cell proliferation
Chiong, M., Cartes-Saavedra, B., Norambuena‐Soto, I., Mondaca‐Ruff, D., Morales, P. E., García-Miguel, M., & Mellado, R. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00072 · Cited by 139
“Mitochondria has four compartments: the outer mitochondrial membrane (OMM), the intermembrane space (IMS), the inner mitochondrial membrane (IMM), and the mitochondrial matrix (Scheffler, 2001).”
BackgroundHu, Q., Shi, H., Zeng, T., Liu, H., Su, Y., Cheng, X., Ye, J., Yin, Y., Liu, M., Zheng, H. W., et al. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1800-z · Cited by 134
The sensing of mitochondrial DAMPs by non-immune cells
Rodríguez‐Nuevo, A., & Antonio Zorzano, A. (2019) · Cell Stress · doi:10.15698/cst2019.06.190 · Cited by 119
“Several studies have reported the relevance of circulating or extracellular mtDNA in TLR9dependent inflammation in diseases such as rheumatoid arthritis [122], atherosclerosis [10, 123], acute liver injury [71], and Streptococcus pneumoniae infections [124], among others [10, 62, 125–129].”
BackgroundFetterman, J. L., Holbrook, M., Westbrook, D. G., Brown, J. A., Feeley, K. P., Bretón‐Romero, R., Linder, E. A., Berk, B. D., Weisbrod, R. M., Widlansky, M. E., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0372-y · Cited by 106
“Damage to mitochondrial DNA has been shown to mediate mitochondrial dysfunction including alterations in calcium handling, oxidant-mediated activation of cell stress pathways, and metabolic disturbances [5, 11, 12, 18].”
BackgroundFang, C., Mo, F., Liu, L., Du, J., Luo, M., Men, K., Na, F., Wang, W., Yang, H., & Wei, X. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0456-1 · Cited by 105
“islands.(20) Given that mtDNA lacks the repair proteins and protective histones found in nuclear DNA (nDNA), mtDNA is more easily attacked by reactive oxygen species (ROS),(21,22) which are byproducts of mitochondrial respiration.”
BackgroundSleep and biological aging: A short review
Carroll, J., & Prather, A. A. (2021) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2021.03.021 · Cited by 95
The role of mitochondrial DNA damage in the development of atherosclerosis
Yu, E., & Bennett, M. R. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.011 · Cited by 92
Self-citationPM2.5 aggravates the lipid accumulation, mitochondrial damage and apoptosis in macrophage foam cells
Liu, J., Liang, S., Du, Z., Zhang, J., Sun, B., Zhao, T., Yang, X., Shi, Y., Duan, J., & Sun, Z. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.03.045 · Cited by 89
Mitochondrial Dysfunction in Vascular Wall Cells and Its Role in Atherosclerosis
Salnikova, D. I., Orekhova, V. A., Grechko, A. V., Starodubova, A. V., Bezsonov, E. E., Попкова, Т. В., & Orekhov, A. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168990 · Cited by 93
“Mitochondrial oxidative stress can exacerbate mitochondrial dysfunction by damaging mtDNA and organelle structures therefore forming a vicious cycle [14,16].”
BackgroundMitochondrial Dysfunction in Cardiovascular Diseases
Yang, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051917 · Cited by 91
“Elevated ROS levels in atherosclerotic plaques have been linked to increased oxidative stress and inflammation [83].”
Zhang, L., Deng, S., Zhao, S., Ai, Y., Zhang, L., Pan, P., Su, X., Tan, H., & Wu, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091425 · Cited by 78
“MtDNA, similar to that of its bacterial ancestors, consists of a circular loop and contains a significant amount of un-methylated DNA present as CpG islands [14].”
BackgroundCarroll, J., Bower, J. E., & Ganz, P. A. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00580-3 · Cited by 81
PCSK9: A novel inflammation modulator in atherosclerosis?
Tang, Z., Li, T., Peng, J., Zheng, J., Li, T., Liu, L., Jiang, Z., & Zheng, X. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27254 · Cited by 75
“A positive bi‐directional interaction was demonstrated between PCSK9 and mitochondrial DNA (mtDNA) damage in VSMCs treated with LPS (Ding et al., 2016). mtDNA damage leads to inflammation, oxidative stress, and apoptosis, which directly contribute to atherosclerosis (Yu & Bennett, 2014, 2016).”
BackgroundProtective Mechanisms of Mitochondria and Heart Function in Diabetes
Aon, M. A., Tocchetti, C. G., Bhatt, N., Paolocci, N., & Cortassa, S. C. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6123 · Cited by 71
“Another important mechanism of hyperglycemic damage involves alterations in mitochondrial DNA (mtDNA) that encodes 37 genes, among them 13 essential OxPhos components (198), thus potentially causing energetic failure and contributing to atherosclerosis (215).”
Chen, S., Xie, X., Wang, Y., Gao, Y., Xie, X., Yang, J., & Ye, J. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.08.051 · Cited by 70
“MtDNA content decrease leads to excess mitochondrial ROS production and subsequently causes transactivation of proatherogenic genes such as plasminogen activator inhibitor-1 (PAI-1), transforming growth factor b1(TGF-b1), vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1), sugges…”
BackgroundResearch progress on the pharmacological effects of berberine targeting mitochondria
Fang, X., Wu, H., Wei, J., Miao, R., Zhang, Y., & Tian, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.982145 · Cited by 75
Control of mitochondrial function and cell growth by the atypical cadherin Fat1
Cao, L. L., Riascos‐Bernal, D. F., Chinnasamy, P., Dunaway, C. M., Hou, R., Pujato, M. A., O'Rourke, B. P., Miskolci, V., Guo, L., Hodgson, L., et al. (2016) · Nature · doi:10.1038/nature20170 · Cited by 67
Emerging role of mitochondria in airborne particulate matter-induced immunotoxicity
Sharma, J., Parsai, K., Raghuwanshi, P., Ali, S. A., Tiwari, V., Bhargava, A., & Mishra, P. K. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.116242 · Cited by 69
Mechanisms of Atherosclerosis Induced by Postprandial Lipemia
Zhao, Y., Liu, L., Yang, S., Liu, G., Pan, L., Gu, C., Wang, Y., Li, D. X., Zhao, R., & Wu, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.636947 · Cited by 68
Role of macrophage extracellular traps in innate immunity and inflammatory disease
Rasmussen, K. H., & Hawkins, C. L. (2022) · Biochemical Society Transactions · doi:10.1042/bst20210962 · Cited by 62
Wu, L., Sowers, J. R., Zhang, Y., & Ren, J. T. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac080 · Cited by 65
Chang, W. C., Zhu, F., Zheng, H., Zhou, Z., Miao, P., Zhao, L., & Mao, Z. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.09.021 · Cited by 60
Mitochondrial fidelity and metabolic agility control immune cell fate and function
Sack, M. N. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120845 · Cited by 54
Mitochondrial regulation of macrophage cholesterol homeostasis
Graham, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.010 · Cited by 55
Senescence in Vascular Smooth Muscle Cells and Atherosclerosis
Zha, Y., Zhuang, W., Yang, Y., Zhou, Y., Li, H., & Liang, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.910580 · Cited by 55
“Nevertheless, long-term mtDNA damage leads to mitochondrial dysfunction and more damaging ROS production, which induces cellular senescence and hastens atherosclerosis development (34).”
BackgroundVita, A. A., Royse, E. A., & Pullen, N. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir1118-414rr · Cited by 51
The alterations of mitochondrial DNA in coronary heart disease
Hu, H., Lin, Y., Xu, X., Lin, S., Chen, X., & Wang, S. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104412 · Cited by 52
Figliuzzi, M., Tironi, M., Longaretti, L., Mancini, A., Teoldi, F., Sangalli, F., & Remuzzi, A. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02812-4 · Cited by 50
Oxidative burden in familial hypercholesterolemia
Mollazadeh, H., Carbone, F., Montecucco, F., Pirro, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26466 · Cited by 48
“Moreover, mtDNA damage induces VSMC apoptosis and accelerates all aspects of atherosclerosis in particular plaque rupture and mitochondrial outer membrane permeabilization (MPTP) opening and apoptosis (Emma & Bennett, 2014).”
BackgroundKoller, A., Fazzini, F., Lamina, C., Rantner, B., Kollerits, B., Stadler, M., Klein-Weigel, P. F., Fraedrich, G., & Kronenberg, F. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13027 · Cited by 47
Jiang, W., Geng, H., Lv, X., Ma, J., Liu, F., Lin, P., & Yan, C. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07018-5 · Cited by 45
Mechanotranduction Pathways in the Regulation of Mitochondrial Homeostasis in Cardiomyocytes
Liao, H., Qi, Y., Ye, Y., Yue, P., Zhang, D., & Li, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.625089 · Cited by 46
“MtDNA damage further stimulates the production of ROS, forming a vicious cycle and aggravating the damage of CMs (Yu and Bennett, 2014; Lee et al., 2017).”
BackgroundZhang, C., Guan, R., Liao, X., Ouyang, C., Liu, J., Ji, L., & Chao, H. (2020) · Inorganic Chemistry Frontiers · doi:10.1039/d0qi00224k · Cited by 42
Mitochondrial DNA: A Key Regulator of Anti-Microbial Innate Immunity
Kausar, S., Yang, L., Abbas, M. N., Hu, X., Zhao, Y., Zhu, Y., & Cui, H. (2020) · Genes · doi:10.3390/genes11010086 · Cited by 40
“Due to common ancestors, DNA of mitochondria shares characteristic features with the bacterial genome, as mitochondrial DNA also consists of unmethylated DNA as CpG islands [6].”
BackgroundOkui, T., Iwashita, M., Rogers, M. A., Halu, A., Atkins, S. K., Kuraoka, S., Abdelhamid, I., Higashi, H., Ramsaroop, A., Aikawa, M., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315007 · Cited by 41
Gao, Y., Xu, W., Dou, X., Wang, H., Zhang, X., Yang, S., Liao, H., Hu, X., & Wang, H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00630 · Cited by 36
“In atherosclerosis, oxidative damage and replication errors are the sources of mtDNA defects, which lead to mitochondrial dysfunction and directly promote atherosclerosis (Yu and Bennett, 2014).”
BackgroundAlvarado‐Vásquez, N. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.05.010 · Cited by 39
“Recently, a review on the role of mtDNA in the development of atherosclerosiswas published (Yu and Bennett, 2014).”
BackgroundThe Role of Mitochondrial DNA in the Development of Ischemia Reperfusion Injury
Hu, Q., Zhou, Q., Wu, J., Wu, X., & Ren, J. (2018) · Shock · doi:10.1097/shk.0000000000001190 · Cited by 39
Markin, A. M., Sobenin, I. A., Grechko, A. V., Zhang, D., & Orekhov, A. N. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00642 · Cited by 41
Volobueva, A. S., Grechko, A. V., Yet, S., Sobenin, I. A., & Orekhov, A. N. (2019) · Biomolecules · doi:10.3390/biom9080377 · Cited by 38
“Mitochondrial dysfunction promotes lipolysis and the increase of serum free fatty acids and glycerol [10].”
BackgroundTracy, E. P., Hughes, W. E., Beare, J. E., Rowe, G., Beyer, A., & LeBlanc, A. J. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0031 · Cited by 39
Jia, Y., Wang, M., Mao, C., Yu, F., Wang, Y., Xiao, R., Jiang, C., Zheng, L., Xu, Q., Zheng, M., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0703-x · Cited by 35
Immunostimulatory role of mitochondrial DAMPs: alarming for pre-eclampsia?
McCarthy, C., & Kenny, L. C. (2016) · American Journal of Reproductive Immunology · doi:10.1111/aji.12526 · Cited by 33
Ali, I., Zhang, H., Zaidi, S. A. A., & Zhou, G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102273 · Cited by 36
Correlation between Mitochondrial Reactive Oxygen and Severity of Atherosclerosis
Dorighello, G. G., Paim, B. A., Kiihl, S. F., Ferreira, M. S., Catharino, R. R., Vercesi, A. E., & Oliveira, H. C. F. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7843685 · Cited by 31
“It has been well recognized that mitochondrial dysfunctions such as opening of the permeability transition pore directly promote inflammation and oxidative stress, phenomena involved in several cardiometabolic diseases [8, 9, 12].”
BackgroundLien, L., Chiou, H., Yeh, H., Chiu, S., Jeng, J., Lin, H., Hu, C., Hsieh, F., & Wei, Y. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006157 · Cited by 31
“Decreased mtDNA content was reported to result in excess mitochondrial ROS production.(33) Increased production of ROS, in turn, leads to oxidative damage to lipids, proteins, and mtDNA.”
BackgroundContis, A., Mitrovic, S., Lavie, J., Douchet, I., Lazaro, E., Truchetet, M., Goizet, C., Contin‐Bordes, C., Schaeverbeke, T., Blanco, P., et al. (2017) · Rheumatology · doi:10.1093/rheumatology/kex041 · Cited by 30
Liu, Y., Peng, C., & Wu, A. (2020) · Aging · doi:10.18632/aging.103120 · Cited by 29
“suggested that mitochondria [7], endothelial dysfunction [8], and interplay between inflammation and immune cells [9, 10] are associated with AS progression.”
BackgroundMitochondrial [dys]function; culprit in pre-eclampsia?
McCarthy, C., & Kenny, L. C. (2016) · Clinical Science · doi:10.1042/cs20160103 · Cited by 29
Cardiovascular Disease, Mitochondria, and Traditional Chinese Medicine
Wang, J., Lin, F., Guo, L., Xiong, X., & Fan, X. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/143145 · Cited by 28
“Mitochondria have been recognised as critical regulators of cell death, generation of ATP, and the generation of reactive oxygen species (ROS), and mtDNA damage leads to mitochondrial dysfunction and promotes atherosclerosis directly [43].”
BackgroundHernández‐Mijares, A., Bañuls, C., Rovira‐Llopis, S., Díaz‐Morales, N., Escribano‐López, I., de Pablo, C., Álvarez, Á., Veses, S., Rocha, M., & Víctor, V. M. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.01.044 · Cited by 28
“Oxidative stress, mitochondrial dysfunction and inflammation are related to cardiovascular diseases (CVD) and atherogenesis [1].”
BackgroundKong, L., Li, K., Gao, L., Yin, A., Zhou, L., Teng, G., & Huang, P. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.110652 · Cited by 28
Mitochondria-Derived Damage-Associated Molecular Patterns in Sepsis: From Bench to Bedside
Li, S., Hu, Q., Huang, J., Wu, X., & Ren, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6914849 · Cited by 29
“Mitochondrial damage promotes the release of mtDNA into the cytoplasm, consequently activating NLRP3 inflammasome and upregulating IL-1β and IL-18 inflammatory factors by caspase-1 [43, 44].”
BackgroundErythrocytes: Member of the immune system that should not be ignored
Ren, Y., Yan, C., & Yang, H. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104039 · Cited by 28
Heteroplasmic Variants of Mitochondrial DNA in Atherosclerotic Lesions of Human Aortic Intima
Sobenin, I. A., Zhelankin, A. V., Khasanova, Z. B., Sinyov, V. V., Medvedeva, L. V., Sagaidak, M. O., Makeev, V. J., Kolmychkova, K. I., Smirnova, A. S., Sukhorukov, V. N., et al. (2019) · Biomolecules · doi:10.3390/biom9090455 · Cited by 30
“The accumulating global data on the mtDNA damage in atherosclerosis [62,63] make this hypothesis plausible, taking in account the role of increased oxidative stress as the mechanistic factor of atherosclerotic risk.”
BackgroundZhang, L., Zheng, X., Huang, Y., Ge, Y., Sun, M., Chen, W., Liu, W., & Li, X. (2021) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2021.109003 · Cited by 26
Li, Y., Yang, S., Jin, X., Li, D. X., Lu, J., Wang, X., & Wu, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1082817 · Cited by 26
“Thus, mitochondria are often targeted for bacterial attack and show functional abnormalities, including mitochondrial reactive oxygen species (mtROS)-induced oxidative stress, mitochondrial DNA (mtDNA) mutation and release, and imbalance of mitochondrial dynamics, further contributing to arterial wall cell damage, inf…”
BackgroundAdvances in the study of the molecular biological mechanisms of radiation-induced brain injury.
Chen, G., Li, W. J., Xu, J., Pang, L., Tang, L., Yu, S., Li, A., Ge, H., Huang, R., & Cheng, H. (2023) · PubMed Central · Cited by 24
Dietary modulation of mitochondrial DNA damage: implications in aging and associated diseases
Lam, J., & McKeague, M. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.07.003 · Cited by 23
Trimetazidine Protects Against Atherosclerosis by Changing Energy Charge and Oxidative Stress
Zheng, S., Du, Y., Peng, Q., Fan, X., Li, J., & Chen, M. (2018) · Medical Science Monitor · doi:10.12659/msm.911317 · Cited by 23
“Recent studies suggested that the development of atherosclerosis is also accompanied by energy depletion [9,10].”
BackgroundSalerno, A. G., Rentz, T., Dorighello, G. G., Marques, A. C., Lorza‐Gil, E., Wanschel, A. C. B. A., de Moraes, A., Vercesi, A. E., & Oliveira, H. C. F. (2019) · Biochemical Journal · doi:10.1042/bcj20190543 · Cited by 21
Gabrielson, M., Vorkapić, E., Folkesson, M., Welander, M., Matussek, A., Dimberg, J., Länne, T., Skogberg, J., & Wågsäter, D. (2016) · Journal of Vascular Research · doi:10.1159/000446653 · Cited by 21
Next-generation sequencing profiling of mitochondrial genomes in gout
Tseng, C., Chen, C., Yen, J., Huang, H., Chang, J., Chang, S., & Liao, W. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1637-5 · Cited by 21
“Indeed, past studies have revealed causal roles of mitochondrial DNA (mtDNA) mutations and mitochondrial dysfunction in diseases with altered metabolism and inflammatory responses, for example, atherosclerosis [2].”
BackgroundRigotti, M., Cerbaro, A. F., Silva, I. D. R., Agostini, F., Branco, C. S., Moura, S., & Salvador, M. M. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13147 · Cited by 21
Luan, Y., Luan, Y., Jiao, Y., Liu, H., Huang, Z., Feng, Q., Pei, J., Yang, Y., & Ren, K. (2023) · Aging and Disease · doi:10.14336/ad.2023.1130 · Cited by 21
THE ROLE OF MUTAGENESIS IN ATHEROSCLEROSIS
Kutikhin, A. G., Sinitsky, M. Y., & Ponasenko, A. V. (2017) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2017-1-92-101 · Cited by 20
“Повреждения митохондриальной ДНК Помимо мутаций в ядерной ДНК одним из ранних звеньев патогенеза атеросклероза являются мутации митохондриальной ДНК (мтДНК) [53-56].”
The aetiology of cardiovascular disease: a role for mitochondrial DNA?
Venter, M., van der Westhuizen, F. H., & Elson, J. L. (2018) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2017-037 · Cited by 20
“Plaque vulnerability is further promoted by mtDNA defects via monocyte cell death and the resultant increased release of inflammatory cytokine.(38) From these studies, it can be seen that mitochondrial dysfunction, possibly as a result of mtDNA variants or damage, can directly be implicated in mechanisms that encumber…”
BackgroundExtracellular DNA in blood products and its potential effects on transfusion
Li, Y., Yang, D., Yang, Q., Fu, C., & Huang, Y. (2020) · Bioscience Reports · doi:10.1042/bsr20192770 · Cited by 20
Organelle dynamics of endothelial mitochondria in diabetic angiopathy
Xiang, H., Song, R., Ouyang, J., Zhu, R., Shu, Z., Liu, Y., Wang, X., Zhang, D., Zhao, J., & Lu, H. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173865 · Cited by 26
Hua, J., Gao, Z., Zhong, S., Wei, B., Zhu, J., & Ying, R. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.08.023 · Cited by 20
New insights into macrophage subsets in atherosclerosis
Wang, Y., Wang, Q. A., & Xu, D. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02224-0 · Cited by 19
“In addition, several studies have demonstrated that mutations in mitochondrial DNA (mtDNA) are associated with key features of atherosclerosis, including inflammation and oxidative stress [6].”
BackgroundScheede‐Bergdahl, C., & Bergdahl, A. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2017-0227 · Cited by 19
Studies of the Formation and Stability of Ezetimibe-Cyclodextrin Inclusion Complexes
Biernacka, M., Ilyich, T. V., Zavodnik, I. B., Palecz, B., & Stępniak, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010455 · Cited by 18
“It is well known that oxidative stress, mitochondrial dysfunction, and inflammation are related to cardiovascular diseases and atherogenesis [40].”
BackgroundOlkowicz, M., Karaś, A., Berkowicz, P., Kaczara, P., Jasztal, A., Kuryłowicz, Z., Fedak, F. A., Rosales-Solano, H., Roy, K. S., Kij, A., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107478 · Cited by 18
Yin, J., Xia, W., Wu, M., Zhang, Y., Huang, S., Zhang, A., & Jia, Z. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.03.002 · Cited by 17
Genetics of Arterial-Wall-Specific Mechanisms in Atherosclerosis: Focus on Mitochondrial Mutations
Orekhov, A. N., Ivanova, E. A., Markin, A. M., Nikiforov, N. G., & Sobenin, I. A. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00873-5 · Cited by 18
Mitochondrial DNA in Exercise-Mediated Innate Immune Responses
Wen, X., Fan, J., Duan, X., Zhu, X., Bai, J., & Zhang, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073069 · Cited by 17
“…activates the myeloid differentiation primary response gene 88 (MyD88), inducing the translocation of nuclear factor kappa-B NF-κ B) and interferon regulatory factor 7 (IRF7) into nucleus to enhance the expression of pro-inflammatory cytokines and type I interferon (IFN-I) respectively [15,36–38].”
Metabolic Strategies in Healthcare: A New Era
Phillips, M. C. L. (2022) · Aging and Disease · doi:10.14336/ad.2021.1018 · Cited by 16
“First, it does not sufficiently address the striking oxidative damage and mitochondria dysfunction observed in human plaques [13,14].”
BackgroundHefti, E., & Blanco, J. G. (2017) · Mitochondrial DNA Part A · doi:10.1080/24701394.2017.1325480 · Cited by 15
The role of hepatocyte mitochondrial DNA in liver injury
Xu, Y., Chu, C., Shi, Z., & Zhang, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115692 · Cited by 19
Zhao, L., Wang, R., Liu, R., Zheng, M., Zhao, L., Li, B., Li, J., Liu, D., He, X., Peng, Q., et al. (2025) · Advanced Science · doi:10.1002/advs.202417128 · Cited by 11
Xu, J., Yang, H., Yang, L., Wang, Z., Qin, X., Zhou, J., Dong, L., Li, J., Zhu, M., Zhang, X., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03462-9 · Cited by 12
Tian, F., Li, J., Liu, X., Tong, T., & Zhang, Z. (2015) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2015.11.004 · Cited by 12
Islam, M. N., Mishra, V. K., Munalisa, R., Parveen, F., Ali, S. F., Akter, K., Ahmed, T., Ho, T., & Huang, C. (2024) · Molecular & Cellular Toxicology · doi:10.1007/s13273-023-00424-4 · Cited by 11
“Atherosclerosis recently resulted in mitochondrial dysfunction and in particular mitochondrial DNA damage despite the poor contribution of mitochondrial to cardiac bioenergetics (Yu and Bennett 2014).”
Gasparini, P. V. F., Matias, A. M., Sales, S. T., Sarter, J. B. B., Siqueira, J. S., Corrêa, C. R., Lima‐Leopoldo, A. P., & Leopoldo, A. S. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000441 · Cited by 11
Peng, S., Tsai, C., Wu, X.-M., Huang, H.-H., Chen, Z., Lee, B., Chang, Y., Pan, C., Wu, V., Chou, C., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10051119 · Cited by 11
“Second, it is close to the electron transport chain, which is the main source of ROS production [35].”
BackgroundRoles of Mitochondrial DNA Signaling in Immune Responses
Wang, L., Liebmen, M., & Wang, X. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6674-0_4 · Cited by 10
Mitochondrial Respiration and Atherosclerosis
Forrester, S. J., & Griendling, K. K. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310298 · Cited by 9
Mitochondrial DNA in atherosclerosis research progress: a mini review
Liu, Z., Huang, N., Liu, C., Wu, C., Zhou, L., Liu, X., & Lei, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1526390 · Cited by 7
“The complex interplay between mtDNA mutations, copy number abnormalities, release, and in fl ammation is increasingly recognized as a central driving factor in AS (13, 16, 17).”
Lin, Y., Yang, Q., Wang, J., Chen, X., Liu, Y., & Zhou, T. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.962635 · Cited by 7
“Mitochondria have been recognized as key regulators of inflammation, cell death, metabolism and ROS production (61).”
Background
Metadata
- Authors
- Yu, E. P. K., & Bennett, M. R.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Yu, Emma P.K.
- Venue
- Trends in Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 25
- Issue
- 9
- Pages
- 481-487
- ISSN
- 1043-2760 (ISSN-L)
- OpenAlex
- W2047242190
- Cited by
- 124
- References
- 64
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 6 · 2023: 7 · 2022: 8 · 2021: 14 · 2020: 20 · 2019: 13 · 2018: 11 · 2017: 9 · 2016: 11 · 2015: 7 · 2014: 2
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Trends in Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (acceptedVersion, cc-by-nc-nd)
- Apollo (University of Cambridge) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- mitochondrial DNA damage, atherosclerosis, mitochondrial dysfunction, reactive oxygen species, oxidative stress, inflammation, cell death, metabolism, therapeutic target
- MeSH terms
- Animals, DNA Damage, DNA, Mitochondrial, Humans, Models, Biological, Apoptosis, Oxidative Stress, Atherosclerosis, Mitochondrial Dynamics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review